OMC
ADPT icon

Old Mission Capital’s Adaptive Biotechnologies ADPT Stock Holding History

Old Mission Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-22,209
Closed -$1.07M – 420
2020
Q2 		$1.07M Buy
+22,209
New +$810K 0.08% 180

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Old Mission Capital's ADPT Position: Q3 2020 in Review

Old Mission Capital sold out of Adaptive Biotechnologies (ADPT) in Q3 2020, closing a stake of 22,209 shares — an estimated $1.07M sold.

Old Mission Capital first reported a position in ADPT in Q2 2020 and held it in 1 quarter. The position peaked at $1.07M in Q2 2020. 206 funds tracked by Wall St. Rank hold ADPT as of Q3 2020.

  • Old Mission Capital reported no remaining Adaptive Biotechnologies position as of Q3 2020 after selling out during the quarter.
  • Old Mission Capital sold 22,209 Adaptive Biotechnologies shares in Q3 2020, an estimated $1.07M.
  • Old Mission Capital first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 1 quarter.
  • Old Mission Capital's Adaptive Biotechnologies position peaked at $1.07M in Q2 2020.
  • 206 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2020.

Based on Old Mission Capital's 13F filing for Q3 2020, filed 16 Nov 2020.